Focusing on inputs has never been as meaningful as measuring output, and the same is true for AI: The engineers who use AI ...

"Our results demonstrate a consistent pattern of clinical activity and favorable safety across patients treated to date," ...

Global AI investment is entering an optimization phase, with $450 billion of hyperscaler capital expenditure in 2026 dedicated to AI infrastructure. Enterprises are prioritizing sustainable operations ...

Enterprise AI budgets are shifting from building to running. Here is what that means for cloud spending, infrastructure, and ...

Program Enters Final Stage of Dose OptimizationData Continue to Demonstrate Strong Clinical Activity and Favorable Safety Across an Expanding Frontline Dataset SEATTLE, WA / ACCESS Newswire / May 6, 2 ...

At ACT Expo, fleet, battery, charging and vehicle leaders said commercial EV adoption is shifting from policy-driven early ...

Enterprises locked in GPU capacity during the AI scramble. Now utilization sits at 5% and the bill is due. Here's what the ...

A phase 1/2, first-in-human, open-label, dose-escalation study of TAK-280, an investigational B7-H3 x CD3ε conditional bispecific redirected activation (COBRA) T-cell engager, in adult patients with ...

What it takes is one internal champion willing to own the process and a leadership team that shows up honestly at the ...

Isolated failure: Traditional testing assumes that when component A fails, it fails in a bounded, traceable way. In a ...

GRASP is a new gradient-based planner for learned dynamics (a “world model”) that makes long-horizon planning practical by (1 ...